Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Leiomyoma × Naproxen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 2 Uterine Diseases 1 Prostatic Neoplasms 1 Pleural Effusion, Malignant 1 Pleural Effusion 1 Lung Neoplasms 1 Leiomyoma 1 Inflammation 1 Hyperuricemia 1 Gout 1 Dysmenorrhea 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Colorectal Neoplasms 1 Cardiovascular Diseases 1 Breast Neoplasms 1 Arthritis 1

Interventions

telapristone acetate 15 ulipristal acetate 14 Uterine Myomectomy 11 vilaprisan 10 Leuprolide 8 asoprisnil 7 Mifepristone 7 relugolix 6 estradiol, norethindrone drug combination 6 elagolix 6 Uterine Artery Embolization 6 Tranexamic Acid 6 ulipristal 5 Estradiol 5 Bupivacaine 5 epigallocatechin gallate 4 Sodium Chloride 4 Norethindrone Acetate 4 Letrozole 4 Hysterectomy 4 linzagolix 3 Vitamin B 6 3 Misoprostol 3 Gonadotropin-Releasing Hormone 3 Embolization, Therapeutic 3 cetrorelix 2 Vitamin D 2 Tea 2 Sugars 2 Saline Solution 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04145518 2025-12-12

MCUP

Endeavor Health

Phase 4 Completed

Dysmenorrhea, Leiomyoma, Pain, Uterine Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡